1?,25-Dihydroxyvitamin D3-3?-(2)-bromoacetate, an affinity labeling derivative of 1?,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells
- 15 July 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (5) , 909-916
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Vitamin D: A millenium perspectiveJournal of Cellular Biochemistry, 2003
- Vitamin D and cancerThe Journal of Nutritional Biochemistry, 2002
- Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer CellsJournal of Biological Chemistry, 2001
- Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α,25-dihydroxyvitamin D3 receptor?☆Steroids, 2001
- Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1α,25-Dihydroxyvitamin D3Biochemistry, 2000
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Roles of the Structure and Orientation of Ligands and Ligand Mimics inside the Ligand-Binding Pocket of the Vitamin D-Binding ProteinBiochemistry, 1997
- 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Vitamin D: A modulator of cell proliferation and differentiationThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell isCell, 1975